Published in
Wiley, Journal of the European Academy of Dermatology and Venereology, 6(30), p. 989-994, 2015
DOI: 10.1111/jdv.13216
Links
- ORCID
- Wiley | PDF
- [curis.ku.dk] | PDF
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [dash.harvard.edu] | PDF
Tools
HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study
Journal article published in 2015 by
A. B. Kimball 
,
J. M. Sobell,
C. C. Zouboulis,
Y. Gu,
D. A. Williams,
M. Sundaram,
H. D. Teixeira,
G. B. E. Jemec
,
J. M. Sobell,
C. C. Zouboulis,
Y. Gu,
D. A. Williams,
M. Sundaram,
H. D. Teixeira,
G. B. E. Jemec
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 